Atlas Trials

A Clinical Study to Evaluate the Efficacy and Safety of Envafolimab Combined With Cetuxima-βand mFOLFOX6 in Patients With MSS, RAS/BRAF Wild-Type Metastatic Colorectal Cancer (mCRC)

Clinical trial NCT06959693 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06959693
Sponsor
Sun Yat-sen University
Status
NOT_YET_RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer (CRC)
Start date
2025-06-01
Primary completion
2028-09-30
Enrollment
590

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.